Our experts will be sharing strategic considerations for phase III clinical trials Tuesday at the 3rd Annual Nonalcoholic Steatohepatitis (NASH) Summit. Meet with our team at booth 5, and don't miss our session on patient recruitment trends with Robert Riccio and Alastair Smith.
Presentation:
Does recruitment in NASH trials have to behave like a rare disease?
Tuesday, Apr. 23
11:15 - 11:45am
Clinical Track
Robert Riccio, Vice President, Hepatology
Alastair Smith, Executive Medical Director, Hepatology
